vTv Therapeutics Inc.VTVTNASDAQ
LOADING
|||
R&D Expense Growth Under Pressure
Trending lower, below historical average.
Left:
||||
Year-over-year research & development expense growth
Latest
-15.07%
↓ 3452% below average
Average (9y)
0.45%
Historical baseline
Range
High:57.96%
Low:-41.89%
CAGR
NaN%
Modest growth trend
| Period | Value |
|---|---|
| 2024 | -15.07% |
| 2023 | 10.02% |
| 2022 | -7.26% |
| 2021 | 20.96% |
| 2020 | -27.14% |
| 2019 | -34.37% |
| 2018 | -41.89% |
| 2017 | -13.35% |
| 2016 | 54.64% |
| 2015 | 57.96% |